Sie sind auf Seite 1von 35

European Journal of Applied Mathematics 20 (2009) 363397 1

A Review of Computational Fluid Dynamics


Analysis of Blood Pumps
M. BEHBAHANI
1
, M. BEHR
1
, M. HORMES
2
, U. STEINSEIFER
2
,
D. ARORA
3
, O. CORONADO
3
, and M. PASQUALI
3

1
Chair for Computational Analysis of Technical Systems, CCES, RWTH Aachen, 52056 Aachen,
Germany
2
Helmholtz Institute, Department of Cardiovascular Engineering, 52056 Aachen, Germany
3
Department of Chemical and Biomolecular Engineering, Rice University, Houston, TX 77005, USA
(Received 10 July 2009)
Ventricular Assist Devices (VADs) provide long- and short-term support to chronically-ill
heart disease patients; these devices are expected to match the remarkable functionality
of the natural heart, which makes their design a very challenging task. Blood pumps,
the principal component of the VADs, must operate over a wide range of owrates and
pressure heads, and minimize the damage to blood cells in the process. They should also
be small to allow easy implantation in both children and adults.
Mathematical methods and Computational Fluid Dynamics (CFD) have recently emerged
as a powerful design tool in this context; a review of the recent advances in the eld is pre-
sented here. This review focuses on the CFD-based design strategies applied to blood ow
in blood pumps and other blood-handling devices. Both simulation methods for blood
ow and blood damage models are reviewed. The literature is put into context with a
discussion of the chronological development in the eld.
The review is illustrated with specic examples drawn from our groups Galerkin/Least-
Squares (GLS) nite element simulations of the basic Newtonian ow problem for the
continuous-ow centrifugal GYRO blood pump.
The GLS formulation is outlined, and modications to include models that better rep-
resent blood rheology are shown. Hemocompatibility analysis of the pump is reviewed in
the context of hemolysis estimations based on dierent blood damage models. Our strain-
based blood damage model that accounts for the viscoleasticity associated with the red
blood cells is reviewed in detail. The viability of trial-and-error based design improvement
and complete simulation-based design optimization schemes are also discussed.
1 Introduction
Computational Fluid Dynamics (CFD) has made impressive progress in the past decade
and has evolved into a promising design tool for the development of biomedical devices.
This article focuses on the evolution and current state of analysis of Ventricular Assist
Devices (VADs) that support the circulatory system of patients suering from Heart
Failure (HF), which is the most common fatal disease in developed countries. Due to the
Corresponding author: behr@cats.rwth-aachen.de
Corresponding author: mp@rice.edu
2 M. Behbahani et al.
permanent shortage of donor hearts available for transplantation, VADs are often the
last hope for end-stage HF patients; these devices can now provide circulatory support
for periods up to 2 years [99]. The blood pump is the key component of a VAD system,
and its design has greatly beneted from CFD; however, the design of blood pumps still
presents signicant challenges.
The main function of a blood pump is to deliver adequate hydraulic performance
while maintaining good hematological compatibility. Hydraulic performance implies the
pumps ability to generate a desired ux at a given pressure head (resistance); hema-
tological requirements arise because non-physiological ow conditions in a pump often
lead to hemolysis (hemoglobin release from red blood cells, or RBCs) and thrombosis
(clotting of blood). Hemolysis beyond a certain level and thrombosis are the two major
life risk factors for patients who depend on a VAD. CFD is an excellent analysis tool to
deliver detailed insight into the complex patterns of blood ow that determine hydraulic
performance. Moreover, in combination with an adequate blood damage model, CFD
allows quantitative prediction of hemolysis. It also supports the engineer in identifying
recirculation areas and other regions with an increased probability for blood clotting.
This article reviews the research in hemodynamics and blood damage analysis. The
presented numerical examples are based on the numerical approaches employed by the
authors research groups, and applied to the simulation of the GYRO centrifugal pump,
under development at Baylor College of Medicine. Statistics pertaining to HF are dis-
cussed in Section 2. Section 3 describes existing types of VADs; the role of CFD in their
design process is analyzed in Section 4. The rheology of blood and some constitutive
models that endeavour to represent the complex ow behaviour of blood are described
in Section 5. Section 6 reviews numerical ow analysis, where blood is considered as
an idealized Newtonian uid. The mathematical models for hemolysis are reviewed in
Section 7. Section 8 describes the numerical solution for the ow of blood modelled as a
viscoelastic Oldroyd-B uid. Aspects of an automatic design optimization are described
in Section 9. In Section 10, we conclude with some future directions for the developments
in the eld.
2 Heart Failure
HF is a clinical syndrome that implies dysfunction of the hearts ventricle and a limited
cardiac performance. HF develops gradually as the heart muscle weakens and causes an
imbalance in pump function, i.e., the heart fails to maintain adequate blood circulation.
The term Congestive Heart Failure (CHF) is used if the reduced pumping ability of the
heart leads to the build-up of uid in the lungs and other body tissues.
By 2004, more than 20 million people suered from HF worldwide, and 2 million
new cases are diagnosed each year [117]. The number of people aicted with HF is
particularly high in the developed countries due to higher life expectancy and older
population. Nutritional life-style including excessive consumption of high-fat food leads
to hyperlipidemia, which constitutes a further risk factor for accelerated atherosclerosis
(formation of plaque in the walls of the arteries leading to narrowing of blood vessels) and
ultimately HF [119]. In the USA alone, 5 million cases of HF were reported in 2002 and
550,000 new cases are reported every year [17]. About 1% of all newborns are aicted
CFD Analysis of Blood Pumps 3
with a debilitating congenital heart defect [75]. On average 49% of men and 32% of
women of age > 40 are at risk of developing HF [17], and it is the most prominent cause
of hospitalization for people aged > 65 [74]. Approximately 20% of the patients die in the
rst year after the diagnosis, and 70-80% have life spans shorter than 8 years. In 2003,
286,700 deaths in USA were caused by HF, representing one in every ve deaths [17].
Heart transplant remains the only permanent treatment for end-stage patients; how-
ever, only 2,500 donor hearts become available each year while 50,000 patients remain
in waiting [51]. The waiting times for patients with an urgent need of heart transplant
are normally longer than 2 years. Anually, care and treatment of HF patients costs the
American Health Care System $29.6 billion [17].
3 Ventricular Assist Devices
As evidenced by the statistics in Section 2, heart transplantation alone cannot suce
as a clinical solution for all HF patients; therefore, Total Articial Hearts (TAHs) as
well as VADs are being increasingly used to provide support to ailing heart and alleviate
suering. For brevity, this article focuses only on computational analysis of VADs; the
modelling and simulation issues are basically the same as in TAHs, and distinction is
blurring with new uses of paired VADs functioning as a TAH.
A VAD is dened as a temporary life-sustaining system which consists of a blood
pump, a power supply and a control unit, and is used to support the blood circulation
by decreasing the workload of the heart while maintaining adequate blood pressure [99].
However, these devices are now being envisaged as permanent clinical solutions.
In 1966, a VAD was successfully implanted into a patient for the rst time. In 1982,
a Jarvik-7 articial heart was implanted in a patient who survived on it for almost 4
months [51]. Since 1990, as new technologies gradually allowed for more ecient heart
pumps, several companies started the development of VADs. In 1994, the U.S. Food and
Drug Administration (FDA) approved left ventricular assist devices (LVADs), i.e., VADs
that specically support the work of the left ventricle, as a bridge to transplant. The 2001
Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart
Failure (REMATCH) study demonstrated that more than twice the number of patients
with end-stage HF survived during a one-year period compared to patients receiving
merely medical therapy [116]. In 2002, the FDA approved the use of LVADs for long-
term therapy in severe HF patients, who cannot be candidates for heart transplants [89].
Anatomically, the VADs are implanted either internally in the abdomen (DeBakey,
Heartmate, Novacor, etc.) or in the pericardial space (Heartware HVAD, etc.), while in
other cases, such as the pulsatile Thoratec VAD, the pump is placed extracorporeally.
Takatani [130] listed more than 30 dierent heart pumps that have been in clinical use
or under development until 2001. The cost of a single VAD is typically over 50,000 US
dollars [7]; however, these devices have the potential to bring overall nancial relief to
the national health systems.
4 M. Behbahani et al.
Table 1. Congurations of mechanical circulatory support and their function.
Conguration Function Typical operating Native heart
condition
supports or replaces
pumping function of 5 L/min at 100 mm Hg
LVAD hearts left ventricle aortic pressure in place
supports or replaces
pumping function of 4 L/min at 40 mm
RVAD hearts right ventricle Hg pulmonary pressure in place
supports or replaces 5 L/min at 100 mm Hg
pumping function of aortic pressure, 4 L/min
BIVAD hearts both ventricles at 40 mm Hg pulmonary pressure in place
5 L/min at 100 mm Hg
aortic pressure, 4 L/min
TAH replaces the heart at 40 mm Hg pulmonary pressure removed
3.1 Current Applications
Table 1 lists the dierent congurations in which VADs are used and their respective
functions. Depending on whether VADs are connected to the left, right or both ventri-
cles, they are referred to as left- (LVAD), right- (RVAD) or bi-ventricular assist device
(BIVAD), respectively. These devices can also be used in a TAH conguration in which
the diseased heart is replaced completely; however, VADs can be removed if the patients
heart recovers. The optimal operating conditions depend on physiological properties of
the patients cardiovascular system. An approach to quantify and parameterize the range
of operating conditions is given in [146].
Based on suggested period of usage, the VADs can be classied into 2-day, 2-week, 6-
month, 2-year and permanent models [98,99]. Table 2 shows current blood pump models,
their applications and associated requirements.
Commercially available VADs exist for short-term support, e.g., during critical surg-
eries, Extracorporeal Membrane Oxygenation (ECMO), Percutaneous Cardiopulmonary
Support (PCPS) to medium and long-term bridging support. A bridge to therapy and
recovery is used to unload partially or completely the diseased heart. Patient studies have
shown that by a prolonged support of the hearts pumping function after several months
up to 1 year, apparent signs of the natural hearts recovery were diagnosed [98, 99]. Af-
ter 2 years, the recovery due to ventricular unloading cannot be improved beyond the
optimum [72]. The bridge to transplant requires a durability that matches the waiting
time for a donor heart which is often more than 2 years. Permanently implantable blood
pumps are currently in development.
CFD Analysis of Blood Pumps 5
Table 2. Blood pump models, their application and associated requirements; X indi-
cates mandatory feature, (X) indicates preferable feature.
Low Without
Durability Hydraulic Anti- sublethal extra-
Blood pump Typical require- perform- thrombo- cell Small corporeal
model application ment ance genicity damage size connection
Short-term: support during
support during extracorporeal
clinical high- cardiopulmo-
risk operation nary bypass 2 days X
Short-term: ECMO,
support during PCPS,
transient cardio- postcardio-
pulmonary tomy cardiac
failure failure 2 weeks X X
Middle-term: treatment of
bridge to dilated cardio-
therapy myopathy 6 months X X X (X)
Long-term: support until
bridge to recovery of
recovery the heart 2 years X X X X (X)
Long-term: support
bridge to until
tranplant transplant > 2 years X X X X (X)
Long-term:
destination permanent
therapy support > 5 years X X X X X
3.2 Design Requirements
The development of a blood pump has to satisfy several general requirements such as
atraumatic behaviour, aordability, control feasibility, reliability, good implantability,
and applicability for dierent physiological demands varying from patient to patient [143].
Apart from such general requirements, dierent applications require dierent pump de-
signs, each of which poses particular technical challenges as listed in Table 2. Often,
design objectives oppose each other and one design criterion is optimized to the detri-
ment of another one. For long-term bridging models, integration of the energy supply
and control unit into the implanted device avoids inammation of the tissue, a frequent
complication occuring to patients using a VAD with extracorporeal connection.
As a blood-pumping device, the VAD has to be designed to provide:
adequate hydraulic performance assisting the physiological pumping, and
good hemocompatibility which implies minimal blood damage.
Blood damage can occur either by thrombosis or hemolysis. Antithrombogenicity and
minimization of hemolysis resulting from high shear stresses [97] are the most important
hematological design features. The two primary damage mechanisms are explained briey
below.
Thrombosis: Thrombosis is the formation of a clot or thrombus and is initiated by
the bodys hemostatic mechanisms to prevent unnecessary bleeding. The processes that
lead to clotting are complex and have been described in Refs. [48, 61, 144] and the refer-
ences therein. The three primary factors can be summarized under the term Virchows
6 M. Behbahani et al.
Table 3. Classication of VADs.
Characteristic
VAD Pump type design features Advantages Disadvantages
large size,
positive- valve system, low durability,
First displacement, large number of more physiological low reliability,
generation pulsatile ow components (pulsatile) condition thrombogenic
spinning impeller,
rotary, bearings and/or compactness,
Second non-pulsatile, seals in direct atraumatic behaviour, sealing issues,
generation continuous ow contact with blood antithrombogenicity leakage issues
only a single
rotary, moving component, compactness,
Third non-pulsatile, spinning impeller, atraumatic behaviour, complex manu-
generation continuous ow magnetic bearings antithrombogenicity facturing process
triad [139]: alterations in blood ow, abnormalities of the vascular wall, and alterations
in the constitution of blood. Therefore, inside VADs, regions of high shear stress, recir-
culation or stagnation and blood contacting surfaces with low hemocompatibility must
be avoided. When the thrombus formation mechanism has been triggered by such non-
physiological causes, it can lead to a pathologically-high degree of clotting. If a thrombus
forms on a surface of the VAD, it may compromise its function, and if it circulates as
a free thrombus in the blood stream, it can occlude blood vessels in vital organs. These
thromboembolic incidents count among the primary causes of death for patients with
ventricular assist support.
Hemolysis: Hemolysis refers to premature RBC damage and its indicator is the release
of hemoglobin from the erythrocyte into the plasma. In articial organs, mechanical
damage resulting from high shear stress levels and exposure times to these stress levels is
the main cause of hemoglobin release; contributions from other eects such as osmosis,
chemical and thermal processes are negligible [11]. Modern atraumatic blood pump design
can avoid catastrophic rupture of RBCs; however, sublethal RBC damage needs to be
reduced for all middle and long-term blood pump models. A more detailed explanation of
hemolysis and the associated physical mechanisms is given in Section 5.3. Minor hemolysis
can raise the level of hemoglobin in the blood to deteriorate the patients condition.
Moreover, a large concentration of plasma free hemoglobin, which must be ltered by
the kidneys, can cause kidney dysfunction [102] and multiple organ failure.
3.3 Classication of VADs
From a technological point of view, VADs can be classied into 3 generations [101, 102];
the charachteristics, advantages and disadvantages of each of them are summarized in
Table 3.
First-generation blood pumps are positive-displacement or pulsatile pumps. In the
CFD Analysis of Blood Pumps 7
1980s, in vivo studies [92, 131, 158] gave evidence that animals could survive for a long
period of time in an entirely depulsed state, proving that pulsatile blood ow does not
represent a necessary physiological condition. Until today, the debate continues among
investigators on whether pulsatile mechanical support provides any substantial benet to
the patient by reproducing the natural heart beat and blood ow. Ref. [137] lists dierent
aspects of pulsatile compared to non-pulsatile perfusion.
Second-generation blood pumps are non-pulsatile pumps. They are characterized by
the use of a spinning impeller providing a continuous blood ow. Typically, second-
generation VADs use contact bearings and/or seals, where the bearings are immersed in
the blood stream or separated from the stream by seals.
The transition from second- to third-generation rotary blood pumps is characterized
by magnetic bearings allowing the impeller to be suspended. Ref. [143] and references
therein argue that the third-generation systems are at present the leading technology in
the development of mechanical circulatory support.
3.4 Rotary Blood Pumps
Rotary pumps can be classied into two categoriescentrifugal and axial. The centrifugal
pumps, e.g., GYRO pump, shown in Figure 1(a), can produce higher pressures at lower
rotational speeds, whereas axial pumps, e.g., MicroMed DeBakey pump, shown in Fig-
ure 1(b), operate at higher speeds to build up the pressure head required for the desired
ow rate [128]. Higher speeds may lead to high shear stresses and thus higher probability
of blood damage. For this reason, centrifugal pumps provide gentler ow conditions;
conversely, the shorter exposure times in axial pumps are expected to play a positive role.
Advantageous applications of centrifugal pumps for VADs and other medical blood ow
devices are described by Curtis [47]. Axial pumps are smaller and consume less power;
therefore, they can be implanted more easily and are more suited for pediatric use. A
description of nine of the most recent and established axial blood pump designs can be
found in Ref. [125]. The particular pump design that is used in some of the numerical
examples later in this article is described below.
GYRO Centrifugal Pump: The GYRO centrifugal pump has been under development
at the Baylor College of Medicine, Houston, Texas [96,97,157]. This pump has an impeller
with six primary (top) and two secondary (bottom) vanes rotating inside a cylindrical
pump housing. The bottom vanes are designed to create a secondary ow that increases
bottom bearing washout. A double-pivot bearing system is used in order to obtain a
sealless pump casing. The pump has a diameter of 6.5 cm and a priming volume of 25
ml. The inow cannula is attached to the upper housing surface and the outow cannula
is attached horizontally to the pump casing, both with a diameter of 0.8 cm. The inow is
positioned eccentrically in the vicinity of the top bearing in order to generate additional
ow around the top shaft with the purpose of further reducing stagnant regions. Under
typical operating conditions, the GYRO pump produces a ow of 5 L/min against 100
mm Hg pressure at a rotor speed of 2,000 rpm.
8 M. Behbahani et al.
Inflow
Outflow
Impeller
Housing
(a) GYRO pump
Stator
Diffusor
Impeller
Straightener
(b) MicroMed DeBakey pump
Figure 1. a) GYRO centrifugal pump and b) MicroMed DeBakey axial pump. Image of
the DeBakey pump courtesy of MicroMed Cardiovascular.
4 Design Tools for Blood Pumps
4.1 Experimental Design Tools
Flow visualization techniques, in vitro and in vivo testing have been traditionally used
to analyze hydraulic and hematologic blood pump features.
Hydraulic testing is mainly performed using Particle Image Velocimetry (PIV) [18, 49]
and Particle Tracking Velocimetry (PTV) [132, 141, 149, 150], which provide the velocity
and stress elds. These techniques can be employed to conrm design expectations and
to identify zones with a high potential for causing hemolysis or thrombus formation. One
limitation of ow visualization lies in its low resolution of critical areas, leading to low-
delity predictions of ow characteristics in zones of particular interest. Generally, this
diculty is dealt with by performing the velocimetry in enlarged models, with associated
scaling issues and problems. Another limitation is the need to perform the measurements
in transparent models [18]. Finally, state-of-the-art visualization methods do not allow
to employ blood as a working uid during testing [132]. A promissing future approach
for measuring velocities of blood particles in blood pumps is the NMR method [33]. The
method allows the use of blood as the test uid and it has been applied to investigate
blood ow in capillaries and tubes [69].
In vitro hematologic testing uses mock circulatory systems [83] which require large
amounts of blood. Human blood is not easily available and no equivalent articial uid
has been produced so far; further restrictions on blood use for experiments are cited
in [64]. As an alternative to human blood for mock up tests, many experimental studies
have used animal blood, which compared to human blood displays dierent behaviour in
terms of rheological properties and mechanical fragility. All these factors exacerbate the
diculties of obtaining a reproducible and quantitatively adequate estimation of blood
trauma based on in vitro testing.
CFD Analysis of Blood Pumps 9
In vivo studies are only able to give information about global design features, as the
device is fully implanted in the living animals circulatory system.
4.2 Numerical Design Tools
CFD made its methodical appearance in the eld of heart pump development in the
1990s. CFD can be employed in the early stages of the design process as well as in later
stages of optimization. Nowadays, the design of medical devices involving blood ow,
such as blood pumps, oxygenators, and articial heart valves, increasingly benets from
CFD modelling.
CFD represents a convenient and ecient tool for the analysis of hydraulic eciency
and ow patterns in the pump. It provides information such as the location and size of
stagnation zones, local shear stress levels and exposure times of RBCs to such stresses;
these parameters can then be correlated to the extent of hemolysis and thrombus for-
mation. In the past decade, progress in blood modelling has made CFD a powerful tool
for the estimation of ow-induced blood damage. Based on hemolysis predictions, it is
possible to perform pump optimization according to blood-specic requirements.
The generally demanding computational resources for CFD studies are compensated
by considerable advantages:
CFD is time- and cost-eective because prototype building and experiments can be
minimized.
CFD can pinpoint the exact ow features inside the device.
Modications of the device model can be easily implemented.
5 Human Blood
5.1 Blood as a Complex and Fragile Fluid
Blood, which exhibits a highly complex, ow-dependent physical, and chemical consti-
tution, is composed of plasma, a Newtonian liquid of viscosity 1 mPa s, RBCs, White
Blood Cells (WBCs) and platelets. Approximately 90% of the plasma is water, and the
rest is composed of dissolved substances, primarily proteins, e.g., albumin, globulin and
brinogen. The volume percentage of plasma typically accounts for 55% and the remain-
ing 45% is almost entirely composed of RBCs. Only up to 1% of the total cell mass in
blood is formed by platelets and WBCs. Platelets are 24 m disk-shaped particles that
are involved in the cellular mechanisms that initiate the wound healing cascade through
the formation of blood clots. The WBCs are responsible for the bodys defense against
infectious disease and foreign materials as part of the immune system. RBCs contain
hemoglobin which has the function of distributing oxygen to the tissues and organs.
Non-physiological conditions, in particular high shear stresses over a prolonged time, can
cause damage to the RBCs. Characteristic shear stresses acting on blood in the human
vessels as opposed to articial organs are listed in [84]. These stresses lie within a range
of 0.11 Pa in healthy human veins and 120 Pa in healthy human arteries, but this value
can increase up to 50 Pa in narrowed arteries caused by stenotic lesions. In articial blood
pumps, typical values are found in a range of 11,000 Pa. Experimental evidence shows
10 M. Behbahani et al.
that in the practical range of exposure times (10 s to 100 ms) RBCs are less resistant
to shear than platelets [70]. The total characteristic residence time of a RBC in a VAD
is on the order of 500 ms.
5.2 Red Blood Cells
RBCs are well-adapted to resist shear stresses encountered under physiological conditions
when blood is pumped through the network of narrow capillaries. When no external
forces act on the membrane, a RBC takes the shape of an axisymmetric, biconcave, disk-
like body. Its dimensions are determined by the elastic properties of the membrane, its
surface area and enclosed volume. RBCs measure typically 6 8 m in diameter and
have a thickness of 2.2 m [29]. Their average volume and surface area are 92 m
3
and
140 m
2
, respectively [59]. Because of its biconcave shape, a RBC has 40% excess surface
area compared to a sphere of the same volume, enabling the cell to undergo deformations
that preserve both volume and surface area. From a mechanical point of view the RBC
can be described as an incompletely inated bag (the plasma membrane) lled with
a viscous uid (the cytoplasm) [142]. The cytoplasm behaves like a Newtonian liquid
with a viscosity of approximately 6 mPa s (cP); it is mostly lled with the glycoprotein
hemoglobin which is equally ecient at binding and releasing oxygen.
5.3 Mechanisms of Hemolysis
The main source of hemolysis in blood pumps is the sublethal damage of the RBCs due
to leaking of hemoglobin rather than catastrophic damage due to rupturing at shear
rates above 42,000 s
1
[86]. Premature hemoglobin release shortens the RBCs normal
life span which for a healthy person is 120 days [29]. Sublethal damage does not occur
immediately under stress but requires time for the RBCs to undergo deformation. The
RBCs at rest aggregate into coin-stack-shaped structures called rouleaux, which disperse
as shear stress increases. The dispersed RBCs preserve their biconcave shape and tumble
in a ow with shear stress below 0.1 Pa [120]. As shear increases, the tumbling slows
and the cells align with the ow at 0.2 Pa. At shear stress greater than 1 Pa, they
deform progressively into prolate ellipsoids with their long axes aligned parallel to the
ow direction. This deformation is accompanied by an orientation of the cell in the shear
planes and a rotational motion of the cell membrane around its contents [142]. Due to its
resemblance with the rotation of the tread of a tank around its wheels, this phenomenon is
referred to as tank-treading. If the cell is deformed by shear stresses that do not exceed a
critical value and exposure time [56], it recovers its natural shape when the forces causing
the deformation are removed. Even peak stress values of 1,000 Pa were found to produce
only insignicant hemolysis if the exposure time did not exceed a few milliseconds [29].
The membrane can support an estimated areal strain of 6% before rupturing and has an
average relaxation time depending on the membrane viscosity and elasticity which was
experimentally determined as 200 ms [71]. Above 150 Pa the membrane reaches its areal
strain limit, microscopic pores in the membrane open and allow hemoglobin to leak into
the blood stream. Extensive hemolysis occurs as a function of the stress and exposure
time [86]. The cell membrane is to a certain extent permeable to water, oxygen, carbon
CFD Analysis of Blood Pumps 11
dioxide and other small molecules but impermeable to hemoglobin [29]. For that reason
the release of hemoglobin Hb into the plasma has been chosen as the indicator for
hemolysis.
In order to assess quantitatively the amount of hemolysis from blood within a mock test
loop, dierent clinical indices have been introduced; the Normalized Index of Hemolysis
(NIH) has become the ASTM standard [4]. The NIH is related to the proportion of
Hb and the total amount of hemoglobin Hb as
NIH(g/100 Lblood) = 100
Hb
Hb
(1 Hct) , (5.1)
where Hct denotes the hematocrit (%), i.e., the proportion of blood volume occupied
by RBCs (45 % for a healthy person and 37 % for normal bovine blood), and is the
hemoglobin content of the blood (150 g/L for a healthy person).
5.4 Rheological Modelling
In large vessels with a diameter more than two orders of magnitude greater than the
size of an RBC, blood can be modelled as a homogeneous uid [34]. At the macroscale,
there exist dierent models with dierent degrees of accuracy in capturing the rheological
behaviour of blood.
In CFD analysis of ow quantities inside VADs blood is usually considered as a New-
tonian uid although it is known to display non-Newtonian properties [53, 136]. Bloods
viscosity is shear-thinning because of the disaggregation of the rouleaux and the orienting
of individual RBCs [40, 41]. Blood also shows nonlinear viscoelastic behaviour resulting
from the elastic membranes of its constituents. Finally blood is thixotropic; its viscos-
ity can vary with time at constant low shear mainly due to rouleau aggregation and
disaggregation. The viscosity of blood depends on the blood sample hematocrit and tem-
perature but in general the qualitative behaviour of any blood sample is the same [54].
In experimental studies [39] it has been shown that at high shear rates (above 100 s
1
),
the viscosity of human blood with 45 % hematocrit reaches a constant value of 3.5 4.0
mPa s, thus justifying somewhat the choice of a Newtonian model for VADs.
Generalized Newtonian constitutive models, which consider shear-thinning eects, have
been used to model blood, e.g., the Carreau-Yasuda model [12,63] and the modied Cross
model [85]. However, complex constitutive models for blood have also been introduced,
where blood is modelled as a viscoelastic uid [6, 103, 154, 156]. In particular, constitutive
equations from the Oldroyd-B class have the best potential for capturing with reason-
able accuracy the rheological behaviour of blood [154, 156] while, at the same time, being
tractable in complex 2-D and 3-D ows. These constitutive equations belong to the more
general conformation tensor class, where the microstructure of the uid is captured by
one or more internal variables [27, 66, 68, 107, 108]. In the Oldroyd-B model, blood is as-
sumed to consist of macromolecules (RBCs) in a Newtonian solvent (the plasma) and is
accordingly modelled as a polymeric solution where the elastic properties of a given ow
are characterized by the dimensionless Weissenberg number Wi = , with being the
relaxation time of the uid, and the shear rate of the ow. Equations of the Oldroyd-B
typei.e., for viscoelastic owshave been used recently in numerical studies of blood
12 M. Behbahani et al.
ow [85, 109]. The eective solution of complex ows of Oldroyd-type uids has been
an important research problem since the late 1970s [45]; recent reviews can be found in
the works of Baaijens [19], Keunings [81], and Owens and Phillips [104]. A very recent
review on currently used models for blood can be found in [103]. An experimental com-
parative study of dierent constitutive models for blood was conducted by Zhang [162].
Owens [103] proposes a new microstructure-based constitutive model for blood built on
polymer network theory with the objective of describing rouleau aggregation and disag-
gregation as well as bloods shear-thinning, viscoelastic and thixotropic properties.
In the nite element context, the solution of viscoelastic ows relies on unequal-order
nite element methods. Unequal-order nite element methods are at a disadvantage com-
pared to equal-order approach due to higher levels of costly indirect memory addressing
on modern cache-based computer architectures.
The fact that today Newtonian modelling is generally used by the scientic community
for VADs stems from its relatively good accuracy for high-shear applications and from
the high computational eort involved in solving complex constitutive models for blood.
We will be modelling blood as a Newtonian uid for the blood pump application in
Sections 6 and 7. For the graft application mentioned in Section 9 where non-Newtonian
eects become important we used a shear-thinning modied Cross model and in Section 8
we describe a numerical method to solve viscoelastic ow for an Oldroyd-B uid.
6 Flow modelling
6.1 Review of Hydraulic Performance Prediction
Table 4 summarizes previous works focusing on or including CFD-based hydraulic e-
ciency investigations of rotary blood pumps. Among the rst numerical simulations to
predict the hydraulic performance and shear stresses inside a blood pump were the stud-
ies performed by Papantonis and Croba [105, 106] and by Pinotti and Rosa [110, 111],
who used a simplied pump model assuming an assembly of parallel co-rotating disks.
A broad variety of dierent blood pump applications have been analysed by the re-
search group from the Universities of Utah and Virginia, ranging from centrifugal [3, 8,
46, 127] and axial [138] pumps for adults to centrifugal [135] and axial [134] pumps for
pediatric use.
Design improvements are generally made by approaches based on the designers intu-
ition. The benet of CFD in this context is that it oers the potential to guide the VAD
designers towards improvements of single pump components [15, 28, 37, 46, 115].
Antaki et al. [9, 36, 145] have stressed the advantages of coupling between numerical
simulation and mathematical optimization techniques with the goal of an optimal design,
which will be reviewed in Section 9.
The complex blood pump geometries have led to the common use of nite dierence
methods based on overset grids, or more frequently, nite element or volume methods
based on unstructured grids. In order to solve the Navier-Stokes equations, adequate
analysis tools are required where the numerical solvers are expected to be robust and
ecient. Table 5 shows which discretization methods are used in combination with the
chosen solvers. Most of the research groups listed in Table 4 have been working with
CFD Analysis of Blood Pumps 13
Table 4. Published research in the eld of hydraulic performance analysis for rotary
blood pumps; AP: Axial Pump, CP: Centrifugal Pump, PVAD: Pediatric VAD.
First author and year Research team Application Solver
Papantonis 1988 Technical University radial pump N/A
[105, 106] of Athens, Greece
Pinotti 1991,1995 Faculty of Mech. Eng. vaneless CP SIMPLE
[110, 111] Campinas, Brazil algorithm
Bludszuweit University of Aries Medical CFX-TASCow
1995 [31] Strathclyde, UK Isoow CP
Antaki 1995 [9] McGowan Center, Streamliner AP STAR-CD
Burgreen 2001 [36] University of PediaFlow PVAD
Wu 2005 [145] Pittsburgh, USA
Yano 1997 [151] Ohio State IVAS CP SMAC algorithm
Ding 1998 [52] University, USA
Nakamura 1999 [94]
Miyazoe 1999 [91] Nikkiso Co., Nikkiso HPM-15 CP CFX-TASCow
Ibaraki University,
Japan
Allaire 1999 [3] University of HeartQuest CP, CFX-TASCow
Anderson 2000 [8] Virginia, AP, PVADs
Curtas 2002 [46] Articial Heart
Throckmorton 2003, Institute, Utah,
2004 [134, 135] USA
Song 2004 [127]
Untaroiu [138]
Ng 2000 [95] Nanyang University, MSCBP CP, CFX-TASCow,
Yu 2005 [159] Singapore AP FLUENT
Chan 2002, 2005 [37, 38]
Qian 2000 [115] University of VentrAssist CP CFX-TASCow
Bertram 2001 [28] New South Wales,
Sydney, Australia
Apel 2001 [10] Helmholtz Institute, Impella CFX-TASCow
Arvand 2004 [15] RWTH Aachen, Intracardiac AP,
Germany Micro Diagonal pump
Watanabe 2001 [140] Shibaura Institute of Biopump BP-80 CFX-TASCow
Technology, Tokyo,
Japan
Behr 2004 [25] CATS, RWTH GYRO CP XNS
Aachen, Germany
Rice University, USA
14 M. Behbahani et al.
Table 5. Solvers and discretization methods
Solver Discretization method
SIMPLE algorithm nite volume
CFX-TASCow hybrid nite volume / nite element
STAR-CD nite volume
SMAC nite dierence
FLUENT nite volume
XNS nite element
the commercially-available numerical solver CFX-TASCow (before 1998 also known by
the names of CFDS-Flow3D and CFX-4), which involves a hybrid nite volume/nite
element methodology in the sense that control volumes are constructed around nodes and
nite elements describe the solution variation within each element. Further commercial
ow solvers for blood pump analysis that have been used in some cases are FLUENT
and STAR-CD. Other research teams used their own implementations of published or
self-developed algorithms, e.g., the Ohio University group listed in Table 4 used a nite
dierence scheme developed by Nakamura [93] based on the SMAC algorithm [5]. The
authors of this review have used an in-house nite element-based code XNS in order to
solve the Navier-Stokes equations of incompressible ow, employing an iterative solver
GMRES [118]. A decision tree and details on the authors choice of the numerical method
can be found in [22].
Results from the works cited in Table 4 show largely satisfactory agreement between
hydraulic performance prediction and experimental results.
6.2 Equations Governing Blood Flow
The isothermal, incompressible ow of a uid in bounded domain
t
and boundary
t
is given by conservation of mass and momentum equations:
(u
,t
+u u f ) (u, p) = 0 on
t
, (6.1)
u = 0 on
t
, (6.2)
where is the uid density (1058 kg/m
3
), u is the uid velocity, u
,t
its time derivative,
p is pressure, and f are body forces per unit mass, e.g., gravity. For a Newtonian uid,
the stress tensor is given as:
(u, p) = pI +T (u), T (u) = 2E(u), (6.3)
CFD Analysis of Blood Pumps 15
where I is the identity tensor, T is the viscous stress, is the viscosity (3.5 mPa s),
E(u) =
1
2
(u + u
T
) is the rate-of-strain tensor, and u is the velocity gradient.
The Dirichlet and Neumann-type boundary conditions are imposed on complementary
subsets (
t
)
g
and (
t
)
h
of the boundary
t
as:
u = g on (
t
)
g
, (6.4)
n (u, p) = h on (
t
)
h
. (6.5)
6.3 Galerkin/Least-Squares (GLS) Formulation
Finite element methods try to nd an approximate solution of partial dierential equa-
tions by solving a discretized form of the governing equations (6.16.2). Since the early
1970s the Galerkin nite element method has been the prevailing method used in struc-
tural mechanics. However, in the context of uid ow simulations, the Galerkin method
exhibits stability problems, e.g., negative numerical diusion which may result in spurious
node-to-node oscillations in velocity for advection-dominated ow. Upwinding schemes [76],
Streamline-Upwind/Petrov-Galerkin (SUPG) methods [35], and Pressure Stabilized/Petrov-
Galerkin (PSPG) methods [133] were developed to overcome these shortcomings of the
Galerkin method. The GLS method [77] used here combines the SUPG and PSPG sta-
bilizations in one conceptually simple term and has proven to have good stabilization,
consistency, and convergence characteristics [57, 58, 77].
In space-time methods, the stabilized nite element formulation of the governing equa-
tions is written over the space-time domain of the problem. The nite element func-
tion spaces are constructed by partitioning the time interval (0, T) into subintervals
I
n
= (t
n
, t
n+1
), where t
n
and t
n+1
are arranged in a sequence of time levels 0 = t
0
<
t
1
< < t
N
= T. Denoting
n
=
tn
and
n
=
tn
, the space-time slab Q
n
is dened
as the domain enclosed by the surfaces
n
,
n+1
, and P
n
, with P
n
being the surface
formed by the boundary
t
as t sweeps through I
n
. Analogous to
t
, surface P
n
is de-
composed into (P
n
)
g
and (P
n
)
h
with regard to the applied boundary condition (Dirichlet
or Neumann). Appropriate nite element interpolation function spaces for the velocity
and pressure are then dened for space-time time slab n(S
h
u
)
n
and (S
h
p
)
n
as well as
corresponding weighting function spaces (V
h
u
)
n
and (V
h
p
)
n
. These spaces are dened as:
(S
h
u
)
n
= {u
h
|u
h
[H
1h
(Q
n
)]
n
sd
, u
h
= g
h
on (P
n
)
g
}, (6.6)
(V
h
u
)
n
= {u
h
|u
h
[H
1h
(Q
n
)]
n
sd
, u
h
= 0 on (P
n
)
g
}, (6.7)
(S
h
p
)
n
= (V
h
p
)
n
= {p
h
|p
h
H
1h
(Q
n
)}. (6.8)
The stabilized space-time GLS formulation can be thus stated as: given (u
h
)

n
, nd
u
h
(S
h
u
)
n
and p
h
(S
h
p
)
n
such that w
h
(V
h
u
)
n
and q
h
(V
h
p
)
n
:

_
w
h
, u
h
,t
+u
h
u
h
f
h
_
Qn
+
_
E(w
h
), (u
h
, p
h
)
_
Qn
+
_
q
h
, u
h
_
Qn
+
(n
el
)n

e=1

mom

_
w
h
,t
+u
h
w
h
_
(w
h
, q
h
),
_
u
h
,t
+u
h
u
h
f
h
_
(u
h
, p
h
)
_
Q
e
n
+
_
(w
h
)
+
n
, (u
h
)
+
n
(u
h
)

n
_
n
=
_
w
h
, h
h
_
(Pn)
h
, (6.9)
16 M. Behbahani et al.
where (, )

are suitable scalar or vector function inner products over domain and
(u
h
)

n
= lim
0
u(t
n
), and
mom
is the stabilization parametersee [26] for details.
The motion of the computational domain boundaries is accomodated by a deforming
boundary-tted mesh. The applied Shear-Slip Mesh Update Method (SSMUM) [23] is a
method that allows the elements in a thin zone of the mesh to undergo shear deforma-
tion followed by limited remeshing that accommodates the desired displacement of one
part of the domain with respect to another.
6.4 Experimental and Numerical Analysis Results
The computational domain and a typical nite element mesh for the GYRO Pump are
shown in Figure 2. The inow boundary
in
and outow boundary
out
form the Neu-
x
z
y

out

in

(a) domain (b) mesh


Figure 2. Computational domain and typical mesh for the GYRO rotary blood pump.
Adapted from [25]. Copyright John Wiley & Sons. Reprinted with permission.
mann portion of the boundary ((
t
)
h
in Section 6.3) of the boundary; the boundary
conditions at the remaining surfaces are of Dirichlet type ((
t
)
g
in Section 6.3). Experi-
mental data is generated using a mock loop as described in [25]. Glycerol and blood are
employed as test uids and the rotational speeds of the impeller used are = 1800, 2000,
and 2200 rpm. In the computations, appropriate pressure head can be applied between

in
and
out
. The gradual ramp-up of that pressure head leads from a strongly transient
to a quasi-stationary condition of the ow eld.
For = 2200 rpm, the ux histories shown in Figure 3 stabilize after 612 revolutions
of the impeller, i.e., they achieve a near-sinusoidal prole with constant average and
amplitude. The simulations were performed for p = 100, 110, 120 and 125 mm Hg
with 800, 800, 1200 and 1000 time steps, respectively [25]. Flow reversal was observed at
p = 130 mm Hg.
The overall hydraulic performance at = 1800, 2000, and 2200 rpm is presented in
Figure 4. The nite range in numerical ux data is due to the low-amplitude periodic
CFD Analysis of Blood Pumps 17
0
1
2
3
4
5
6
7
0 1 2 3 4 5 6 7 8
Time (rev)
F
l
u
x

(
l
/
m
i
n
)
(a) p = 100 mm Hg
0
1
2
3
4
5
6
7
0 2 4 6 8 10 12
Time (rev)
F
l
u
x
(
l
/
m
i
n
)
110 mm Hg
120 mm Hg
125 mm Hg
(b) p = 110125 mm Hg
Figure 3. Flux histories at
out
at = 2200 rpm and p = 100, 110, 120 and 125 mm
Hg. Adapted from [25]. Copyright John Wiley & Sons. Reprinted with permission.
changes in the computed signal. Numerical prediction and experimental values are in
good agreement for = 1800 and 2000 rpm, while a considerable dierence is observed
at = 2200 rpm, which is attributed to the limitation of the turbulence model.
All computations were performed on a Linux PC cluster, with Myrinet interconnect, on
partitions ranging from 32 to 72 CPUs, and requiring 48 hours to obtain a quasi-steady
ux at each ow condition.
7 Numerical Analysis of Blood Damage
7.1 Blood Damage Modelling
In spite of the intense research on blood damage modelling, there is currently no consensus
on suitable models that relate uid dynamics information, such as stress and shear rate,
to clinical properties, such as the NIH.
Correlations for blood damage in articial organs were established under the assump-
tion of experimentally feasible conditions, which implied hemolysis under steady shear
at short time intervals. Assuming that blood damage depends solely on shear stress and
exposure time, several researchers have used a mathematical power-law model [65] to
formulate hemoglobin release based on experimental data:
Hb
Hb
= C
a
t
b
, (7.1)
where
Hb
Hb
is the ratio of hemoglobin in the plasma to the total hemoglobin, is the scalar
measure of the shear stress acting on the blood in Pa, and t is the time duration of blood
exposure to the shear stress in seconds. Gu and Smith [67] used a benchmark approach
for an evaluation of dierent existing models presented by Giersiepen et al. [62], Heuser
and Opitz [73], and Grigioni et al. [65] to evaluate the blood damage prediction accuracy
of such models compared to experimental data. For hematological CFD-design of VADs,
the most commonly adopted model considering steady-shear hemolysis experiments, is
the one established by Giersiepen et al. [62] who derived the constants C, a and b from
18 M. Behbahani et al.
Time (rev)
Time (rev)
Time (rev)
F
l
u
x
(
l
/
m
i
n
)
F
l
u
x
(
l
/
m
i
n
)
F
l
u
x
(
l
/
m
i
n
)
Figure 4. Hydraulic performance of the Gyro pump: experiment (black) versus simulation
(shaded). Some of the previously shown time histories of the ux are also shown. Adapted
from [25]. Copyright John Wiley & Sons. Reprinted with permission.
an empirical study in a cylindrical Couette system undertaken by Wurzinger et al. [147].
The following correlation was found:
Hb
Hb
= 3.62 10
7

2.416
t
0.785
. (7.2)
Further studies in a modied Couette system including measurements for time-varying
shear stress were performed by Klaus [82], who uses an improved sealing system to exclude
eects of temperature-induced hemolysis. Dierent authors have applied comparative
stress theory to compute the scalar measure of in equation (7.1) from the second
invariant of the deviatoric stress tensor:
= (II
T
)
1
2
=
_
1
2
T : T
_1
2
. (7.3)
In the following, this method of computing hemolysis will be referred to as stress-based
method; it assumes that the RBCs response to load is immediate and independent of its
load history. Bludszuweit [31] expressed the scalar shear stress value based on the von
CFD Analysis of Blood Pumps 19
Mises criterion [79] which is calculated from the six components of the stress tensor:
=
_
1
6
_
(
xx

yy
)
2
+ (
yy

zz
)
2
+ (
zz

xx
)
2
_
+
_

2
xy
+
2
yz
+
2
zx
_
_1
2
. (7.4)
Since then, this approach has been further elaborated to include some aspects of stress
threshold and aging, as well as calibration for a specic device [15, 64, 155].
In contrast to the stress-based method, the authors group presented a strain-based
approach which will be described in Section 7.3.
7.2 Evaluation of Hemolysis Simulations
Equation (7.4) was introduced to assign scalar stress values to pathlines, where each
of them represents a particles path through the blood pump chamber. Based on this
approach, Bludszuweit [32] described the methodology on how CFD can be used for
hemolysis predictions in articial organs and calculated overall damage as the sum of the
partial inuences of the loading function assuming constant and cyclic load functions to
reect RBCs damage behaviour or resistance. In Refs. [3032], the stress-loading time
functions for individual particles are determined for the Aries Medical Isoow centrifugal
blood pump and other types of articial organs.
Between 1995 and 2001 other researchers began to use CFD in order to nd a good
hematological design for centrifugal blood pumps [88, 159], axial blood pumps [11] or
simplied blood pump models [111, 153] by relating local ow conditions to hemolysis. In
those studies, hemolysis was discussed but blood damage was not quantied. In absence
of quantitative hemolysis results, some authors interpreted peak stresses as threshhold
levels for the occurence of hemolysis [159].
By comparison to experimental data, it was found that equation (7.2) tends to overes-
timate the actual blood damage in articial organs. To cite some examples, De Wachter
and Verdonck [50] found the computed hemolysis values for cannulae to lie in a range
between 2 to 8 times the measured values, Goubergrits and Aeld [64] found a com-
puted overestimation factor of 25 for a standard Bjork-Shiley valve and Yano et al. [152]
found a factor of 30 for the case of an axial blood pump; in all these cases, a stress-
based approach was used. Grigioni et al. [65] draw attention to the inherent limitations
of hemolysis estimations based on power-laws such as the one proposed by Giersiepen et
al. [62], and highlight the eect of a time-varying loading acting on RBCs, showing the
need for a reassessment of the power-law model; or more precisely, the interpretation of
the stress measure used in that model.
More recently, quantitative hematological CFD results based on a stress-based model
and considering blood as a Newtonian uid have been published for rotary blood pump
designs [15,16,37,90,124,127,161] and for pulsatile blood pumps [100]. These authors used
either Giersiepens power-law equation (7.2) or Bludszuweits stress model equation (7.4),
or both. For the above mentioned rotary blood pump simulations, TASCow was typically
chosen as the solver and a Lagrangian particle tracking method was applied to add up
the hemoglobin leakages along streamlines. Some novel approaches and insights regarding
hemolysis predictions have been introduced:
Comparative studies: Song et al. [124, 127], Mitoh et al. [90] and Zhang et al. [161]
20 M. Behbahani et al.
reported good agreement of CFD blood damage predictions with experimental hemolysis
data, thus demonstrating that CFD is a viable approach to analyze blood behaviour in
a VAD.
Choice of best design alternative: Arvand et al. [15] and Chan et al. [37] undertook their
studies with the objective of nding the best hematological design for individual blood
pump components from a predetermined set of dierent design options by comparing the
computed blood damage rates for the competing design candidates.
Semi-empirical pump-specic hemolysis model: Arvand et al. [16] set the estimated hemol-
ysis index equal to the measured index and determined the constants of the power-law by
regression analysis in order to receive the best t. This results in an optimized hemolysis
model, albeit restricted to a single pump conguration.
Shape optimization: Wu et al. [145] proposed a parameterized geometry model of the
blood pump and demonstrated an automatical optimization design approach; this topic
is further discussed in Section 9.
Inuence of turbulence: Some researchers have stressed the important role of turbulence.
Kameneva et al. [80] performed experiments in combination with CFD studies and found
signicantly varying hemolysis values at constant shear stress values for turbulent com-
pared to laminar ow. In a comparative study between PIV and CFD-based analysis,
Song et al. [126] found that the accuracy of ow predictions depends on the applied
turbulence model, especially in near-wall regions.
Inuence of device orientation: Yuri et al. [160] found that the implantation position and
orientation of the blood pump in the patient can have an inuence on hemolysis. This
is especially the case for the GYRO pump where implantation orientation aects the
location of the magnetically levitated impeller.
7.3 Modelling of RBC Strain
As an alternative to stress-based models our research team has recently proposed a more
fundamental approach [13] that takes into account the time-dependent history of RBC
deformation, which may not correspond to the instantaneous shear stress levels in the
surrounding uid. This approach requires a mathematical representation of the RBC
geometry.
In the scientic literature models of RBC deformation can be found in works focusing
on microscale blood ow where RBCs are usually modelled as capsules [148]. A capsule
is a particle with an elastic membrane enclosing a uid. A description of the modelling
and simulation of capsules can be found in [112, 114]. Applications of this approach to
RBCs include simulation of simple shear ow [55, 113], capillary ow [122] and rouleau
aggregation [20]. It was observed that RBCs in shear ow behave as liquid droplets [60,
120]. In droplets, as opposed to capsules, the interfacial forces arise from surface tension.
Microcapsules and biological cells such as RBCs represent an intermediate case between
elastic solid particles and liquid droplets, behaving rather as a solid-like body in the low
shear regime and attaining a steady-state orientation with a tank-treading motion of the
membrane only at high shear rates [21, 123].
Therefore in blood pumps where shear forces are typically high, our research group
uses the simplied model of RBCs as neutrally-buoyant droplets. Other authors have
CFD Analysis of Blood Pumps 21
also used a droplet analogy to simulate RBC ow behaviour in small and intermediate
vessels [43, 44, 121].
In our model the RBC shape is described by an evolution equation that incorporates
specic characteristics of RBCs including shape recovery in the absence of shear and
tank-treading motion. The RBC shape is simply described by a symmetric positive-
denite morphology tensor, which is subject to deformations due to forces exerted by
the surrounding liquid. These forces compete with the interfacial tension, which tends to
reduce the elongation of the ellipsoid, which can be modelled as spherical-shape restora-
tion force (at high shear). A frame-invariant droplet deformation equation was proposed
by Maetone and Minale [87], which accounts for non-ane droplet deformation, and
extended by Arora et al. [13] to represent tank-treading:
dB
dt
[ B B ] = f
1
[B g(B)I] + f
2
_

E B +B

E
_
+ f
3
_

W B B

W
_
, (7.5)
where B is the morphology tensor, W =
1
2
(uu
T
) is the vorticity tensor, g(B) =
3 III
II
(involving third and second invariant of B), f
1
= 5.0 s
1
based on RBC relaxation time,
and f
2
= f
3
= 1.25 10
3
are uniquely determined by RBC behaviour in steady shear
ow. The orthonormal matrix denes the rate of rotation of a reference frame attached
to the eigenvectors of B, leading to

E = E, and

W = W. At any instant, the ow eld
is simulated and the morphology tensor evolution is tracked along pathlines through the
pump. In this way, equation (7.5) yields information about the deformation, or strain,
of the RBC at each point in the ow eld. Because RBCs experiencing varying shear
stresses require time to change their shape, the calculated strain acting on the blood
cell does not lead to an instantaneous deformation as in the way predicted by steady-
shear experiments. Therefore, the computed deformation of the RBC is correlated to a
hypothetical shear that would lead to such deformation under steady conditions. Based on
these shear values, the hemolysis rate can be computed using the experimental correlation
given by the equation (7.2). Next, the hemolysis rate is integrated along each pathline to
calculate blood damage for individual RBCs, and by taking the average over a suciently-
high number of pathlines, it is possible to calculate the hemoglobin release in the blood
pump; this approach is referred to as the strain-based model [13].
Figure 5 schematically shows the dierence between the stress- and strain-based mod-
elling approaches.
8 Viscoelastic Modelling of Blood
The authors have been developing Galerkin Least Squares-type (GLS) nite element
methods for solving the ow of viscoelastic uids [22, 24, 42]; the most recent version is
the GLS4 method [42], where the equations of the ow are converted into a set of rst-
order partial dierential equations, and the four ow eld variables (velocity, pressure,
velocity gradient, and elastic stress) are represented explicitly by basis functionshence
the name GLS4. This method is outlined below as an example of the mathematical
complexity needed to handle viscoelastic ow equations.
22 M. Behbahani et al.
steady simple shear
hemolysis experiments
h
e
m
o
l
y
s
i
s
shear stress strain
strain-based
stress-based
h
e
m
o
l
y
s
i
s
Figure 5. Stress- and strain-based hemolysis predictions for the centrifugal blood pump.
Adapted from [14]. Copyright Blackwell Publishing. Reprinted with permission.
The GLS4 method is attractive for large-scale computations, e.g., ow in a complicated
three-dimensional blood pump. One characteristic of the GLS4 method is the use of low-
and equal-order interpolation functions for all variables, which makes the method ecient
and easy to implement on distributed-memory clusters.
In addition to the conservation of momentum and mass equations (6.1)(6.2), the
traceless velocity gradient and the transport of conformation are considered; the traceless
velocity gradient L is dened as:
L = u
1
tr I
( u) I, (8.1)
where tr denotes trace, while the conformation tensor M for the Oldroyd-B model obeys
the evolution equation:
Wi (u ML
T
MM L) + (MI) = 0, (8.2)
where the non-dimensional Weissenberg number Wi represents the product of the relax-
ation time and the shear rate of the ow.
Equation (6.3), for the Oldroyd-B model, expands to:
= pI +T
1
+T
2
, T
1
=
s
(L +L
T
), T
2
=

p

(MI), (8.3)
where is the stress tensor, T
1
is the viscous stress, T
2
is the elastic contribution to
the stress,
s
is the solvent viscosity,
p
is the polymer contribution to the viscosity, and
is the relaxation time of the viscoelastic uid. The GLS4 formulation for steady ow
of an inertialess incompressible viscoelastic uid occupying a spatial domain is: Find
CFD Analysis of Blood Pumps 23
u
h
S
h
u
, p
h
S
h
p
, L
h
S
h
L
and M
h
S
h
M
such that:
_

w
h
:
h
d +
_

h
w
h
h
h
d +
_

mom
_
q
h
(E
h
+ (E
h
)
T
)
(1 )
Wi
S
h
_

_

h

d +
_

q
h
( u
h
)d +
_

cont
( w
h
)( u
h
)d +
_

E
h
:
_
L
h
u
h
+
1
tr I
( u
h
)I
_
d +
_

gradu
_
E
h
w
h
+
1
tr I
( w
h
)I
_
:
_
L
h
u
h
+
1
tr I
( u
h
)I
_
d +
_

S
h
:
_
Wi(u
h
M
h
(L
h
)
T
M
h
M
h
L
h
) + (M
h
I)
_
d +
_

cons
_
Wi (u
h
S
h
(L
h
)
T
S
h
S
h
L
h
) +S
h
_
:
_
Wi (u
h
M
h
(L
h
)
T
M
h
M
h
L
h
) + (M
h
I)
_
d = 0,
q
h
V
h
p
, w
h
V
h
u
, E
h
V
h
L
, S
h
V
h
M
, (8.4)
where =
s
s+p
is the viscosity ratio, S
h
and V
h
are suitably-dened interpolation
and weighting function spaces for the velocity, pressure, velocity gradient and confor-
mation and
mom
,
cont
,
gradv
and
cons
are the least-squares stabilization parameters
for the momentum, continuity, interpolated traceless velocity gradient and constitutive
equations, dened as

mom
=
h
2
4
,
cont
= 0,
gradv
= 1, (8.5)

cons
=
_
1 + (Wi L
h
)
2
+
_
2Wiu
h

h
_
2
_
1/2
, (8.6)
where h is the dimensionless element length. This formulation has been applied to a
benchmark problem of an Oldroyd-B uid past a circular cylinder in a channel with a
width being 2 times the cylinder diameter [42], where good agreement with the published
results [78, 129] was found. The GLS4 method may be of course extended to unsteady
ows; however, such extension has not been yet tested.
9 Design Optimization
In the context of blood pump development, considerable research on CFD-based design
optimization has been made by Antaki et al. [9], Burgreen et al. [36], and Wu et al. [145].
The expression design optimization does not admit a universally accepted interpretation
and is often confounded with the term design improvement. Design optimization denotes
24 M. Behbahani et al.
an automated iterative improvement process, in which numerical simulation is coupled
with optimization techniques. This fully automated procedure stands in marked contrast
to a design approach including a human expert in the iteration loop. The design opti-
mization process is an iterative approach which has been described in Refs. [9, 36] and
consists in the following steps:
An initial shape of the device is dened,
geometrical featues which are chosen to be variable are parametrized,
objective functions are dened resulting in a specied performance index,
CFD simulations are performed to characterize the ow eld in terms of uid dynamics
properties,
the objective function and its gradient are computed or estimated and analyzed with
respect to their optimality,
as long as the performance index is sub-optimal the shape parameters are modied
and an additional iteration is performed.
Requirements and specic aspects for design optimization compared to design improve-
ment are listed in Table 6.
The design optimization strategy for blood pumps was rst presented by Antaki et
al. [9], but many obstacles made its application a dicult task. According to Antaki
et al. [9], the main challenges lie in nding enhanced models for the description of the
blood ow, a better description of the relationship between macroscopic and microscopic
blood ow features, and adequate automated algorithms for performing shape changes
in response to computed ow features.
Design optimization is a systematic methodology. For the iterations, neither heuristic
knowledge nor human interaction is required and cut-and-try approaches are avoided.
As the complexity of the problem rises, it becomes an increasingly time-saving and ef-
cient method leading to an optimal solution. A particularly strong benet of design
optimization is the possibility of reaching an optimal compromise between competing
design objectives by means of dening a corresponding performance index.
Wu et al. [145] presented results from CFD-based design optimization for the improve-
ment of ow characteristics of a blood pump impeller. In this case blood was assumed to
be Newtonian.
The authors group has also successfully applied design optimization for steady [1] and
unsteady [2] blood ows. These study cases include arterial grafts and are less complex
than a blood pump as far as geometry is concerned; however, additional complexity was
introduced by modelling blood as a shear-thinning uid.
In our study the goal was to nd a shape () for the graft such that a given objective
function J, which depends on the design variable , is minimized. The Navier-Stokes
equations (6.16.2) are written as a generic state equation:
c(u, p; x) = 0. (9.1)
CFD Analysis of Blood Pumps 25
Table 6. Features and requirements of design optimization and design improvement.
Design Design
optimization improvement
Blood pump complex parametric simple non-parametric
model geometry model required geometry model sucient
Blood ow enhanced model enhanced model
model required desirable
computation of ow eld and
Computational its derivatives for shape changes, computation of ow eld,
eort many iterations few iterations
Solver ecient solver required ecient solver required
Computational cost very high high
Mesh adaptation automated manual
Degree of fully automated approach, heuristic knowledge and
automation limited human interaction required human interaction required
optimal compromise between
competing design criteria can be competing design
Competing found by dening objective functions objectives add diculties
design criteria and a corresponding performance index in nding best compromise
optimal result,
can solve highly complex cases, can nd best solution
optimal solution can be found in a set of intuition-based
Obtainable result outside the scope of human intuition alternatives
The set of admissible shapes can be parameterized by A
ad
R
n
, so that the optimal
design problem is given as follows:
minimize J(), (9.2)
subject to c(u(), p(); x()) with = (), (9.3)
A
ad
. (9.4)
In order to avoid high-shear regions in the graft the objective function is chosen as the
integral of the squared shear rate over the observation region
obs
() ().
J() = 2
_

obs
()
E(u) : E(u)dx. (9.5)
The discrete state equation is written as:
c
h
(v
h
(), x
h
()) = 0, (9.6)
26 M. Behbahani et al.
where v
h
= (u
h
, p
h
). The discrete counterpart of the optimization problem can be written
as:
minimize

J
h
(), (9.7)
subject to A
ad
, (9.8)
where

J
h
() = J
h
(v
h
(), x
h
(), ). We use a gradient-based algorithm to solve the
problem, where the gradient of

J
h
with respect to is given by

J
h
=
J
h

+
J
h
x
h
dx
h
d
+
J
h
v
h
dv
h
d
. (9.9)
By computing the new = + can be determined and the mesh x
h
() is updated
for the next iteration.
As a result of the performed analysis, it became clear that the optimal shape can show
striking discrepancies in terms of uid dynamic parameters for optimization results based
on dierent constitutive models.
10 Conclusion
We have presented a review of current VAD designs, described their design requirements
and outlined the important role of CFD in the context of VAD development.
We have then reviewed current understanding of the complex structure of blood, in-
cluding its shear-thinning and viscoelastic behaviour, as well as tank-treading of RBCs.
We have further presented an overview of published research and current state-of-
the-art methods for the analysis of blood ow processes in VADs. Details on numerical
computations performed by our research team including quantitative results for unsteady
blood ow have been given for the GYRO blood pump. We have shown that CFD-
based predictions of hydraulic pump performance t well the experimental data at lower
rotational speeds. It is expected that the implementation of a more accurate turbulence
model will be able to achieve better agreement for higher impeller rotational speeds.
Most of the works reviewed in this paper assume blood behaves like a Newtonian uid
and reduce the 3-dimensional shear-forces acting on the RBCs by a scalar shear-stress
value, which is then correlated to experimental results under steady ow. We called this
method stress-based, as it assumes immediate response of RBCs to instantaneous stress
values.
We have pointed out that predicting mechanical hemolysis in a blood pump is a more
complex task and requires realistic hemorheological and blood damage models.
To that end, our research team has developed a tensor RBC model, derived from a
model of a deforming droplet and modied to include tank-treading. By computing the
morphological change of the RBCs along their pathlines through the pump, it is possible
to determine hemolysis based on the RBC deformation; we called this approach a strain-
based method.
We have reviewed viscoelastic modelling of blood with the Oldroyd-B model. The
GLS4 method for solving steady ow of viscoelastic uids has been reviewed, which is
easy to implement as it uses equal order polynomial interpolations for all variables. Our
CFD Analysis of Blood Pumps 27
research team is working on the development of the unsteady GLS4 method to simulate
the ow through blood pumps.
The advances of design optimization in the eld of VAD development have been re-
viewed and it was concluded that, whereas the optimization strategy has already been
well described in its theory, it has not yet been applied for a complex parameterized blood
pump model. Demanding implementation and computational requirements have made its
application dicult. However, we have discussed the advantages of design optimization
compared to a mere design improvement strategy and believe that design optimization
has a powerful potential.
Future research will be directed towards further elaboration of blood and hemolysis
models. The implementation of adequate turbulence models becomes important espe-
cially at high rotational speeds. The development of a thrombosis model, although not
discussed in detail in this article, will be of importance in order to treat the subject
of blood damage in a holistic manner. Comparative studies in blood pumps between a
stress-based and a strain-based method for calculating hemolysis will serve to evaluate
the predictive potential of these methods. Possibilities to further increase the performance
of the GLS4 method, as specied in Ref. [42] are also being considered.
In the context of design optimization the research for realistic constitutive blood models
will be of particular importance, as dierent results may be obtained depending on the
constitutive model.
Acknowledgement
This work was supported by the National Science Foundation under award CTS-ITR-
0312764, the MicroMed company, and by the German Science Foundation under the
GSC 111, SFB 401, SFB 540, SPP1253, SPP 1273 programs and by JARA Seed funds.
Computing resources were provided by the RWTH Aachen University Center for Com-
puting and Communication and by the Forschungszentrum J ulich. Additional computing
resources were provided by the Rice CRAY XD1 Cluster, funded by NSF through an MRI
award CNS-0421109, Rice University, AMD and CRAY, and by the Rice Terascale Cluster
funded by NSF under grant EIA-0216467, Intel, and Hewlett-Packard. Further research
in the eld is supported by grant 1R01HL085054-01A2 from Texas Heart Institute. We
wish to thank Mr. Bob Benkowski from MicroMed for his strong support.
References
[1] F. Abraham, M. Behr, and M. Heinkenschloss. Shape optimization in steady blood ow:
A numerical study of non-Newtonian eects. Computer Methods in Biomechanics and
Biomedical Engineering, 8(2):127137, 2005.
[2] F. Abraham, M. Behr, and M. Heinkenschloss. Shape optimization in unsteady blood ow:
A numerical study of non-Newtonian eects. Computer Methods in Biomechanics and
Biomedical Engineering, 8(3):201212, 2005.
[3] P.E. Allaire, H.G. Wood, R.S. Awad, and D.B. Olsen. Blood ow in a continuous ow
ventricular assist device. Articial Organs, 23(8):769773, 1999.
[4] American Society for Testing and Materials. Standard practice for assessment of hemolysis
in continuous ow blood pumps. Standard F 1841 - 97, ASTM, 1997.
28 M. Behbahani et al.
[5] A.A. Amsden and F.H. Harlow. The SMAC method: A numerical technique for calculating
incompressible uid ows. Technical Report LA4370, Los Alamos Scientic Lab., New
Mexico, USA, January 1970.
[6] M. Anand and K.R. Rajagopal. A shear-thinning uid model for describing the ow of
blood. International Journal of Cardiovascular Medicine and Science, 4(2):5968, 2004.
[7] D.W. Anderson. Blood pumps: Technologies and markets in transformation. Articial
Organs, 25(5):406410, 2001.
[8] J.B. Anderson, H.G. Wood, P.E. Allaire, G. Bearnson, and P. Khanwilkar. Computational
ow study of the continuous ow ventricular assist device, prototype number 3 blood
pump. Articial Organs, 24(5):377385, 2000.
[9] J.F. Antaki, O. Ghattas, G.W. Burgreen, and B. He. Computational ow optimization of
rotary blood pump components. Articial Organs, 19(7):608615, 1995.
[10] J. Apel, F. Neudel, and H. Reul. Computational uid dynamics and experimental valida-
tion of a microaxial blood pump. ASAIO, 47:552558, 2001.
[11] J. Apel, R. Paul, S. Klaus, T. Siess, and H. Reul. Assessment of hemolysis related quan-
tities in a microaxial blood pump by computational uid dynamics. Articial Organs,
25(5):341347, 2001.
[12] D. Arora. Computational hemodynamics: Hemolysis and viscoelasticity. PhD thesis, Rice
University, Department of Mechanical Engineering and Materials Science, 2005.
[13] D. Arora, M. Behr, and M. Pasquali. A tensor-based measure for estimating blood damage.
Articial Organs, 28(11):10021015, 2004.
[14] D. Arora, M. Behr, and M. Pasquali. Hemolysis estimation in a centrifugal blood pump
using a tensor-based measure. Articial Organs, 30:539547, 2006.
[15] A. Arvand, N. Hahn, M. Hormes, M. Akdis, M. Martin, and H. Reul. Comparison of
hydraulic and hemolytic properties of dierent impeller designs of an implantable rotary
blood pump by computational uid dynamics. Articial Organs, 28(10):892898, 2004.
[16] A. Arvand, M. Hormes, and H. Reul. A validated computational uid dynamics model to
estimate hemolysis in a rotary blood pump. Articial Organs, 29(7):531540, 2005.
[17] The American Heart Association. Heart disease and stroke statistics2006 update. Cir-
culation, 2006.
[18] I. Avrahami, S. Einav, M. Rosenfeld, and K. Aeld. Hemodynamic aspects of the Berlin
ventricle assist device. In Proceedings of the 23rd Annual EMBS International Confer-
ence, October 25-28, pages 468472, 2001.
[19] F.P.T. Baaijens. Mixed nite element methods for viscoelastic ow analysis: A review.
Journal of Non-Newtonian Fluid Mechanics, 79:361385, 1998.
[20] P. Bagchi, P.C. Johnson, and A.S. Popel. Computational uid dynamic simulation of
aggregation of deformable cells in a shear ow. Journal of Biomechanical Engineering,
127:10701080, 2005.
[21] D. Barth`es-Biesel and H. Sgaier. Role of membrane viscosity in the orientation and de-
formation of a spherical capsule suspended in shear ows. Journal of Fluid Mechanics,
160:119135, 1985.
[22] M. Behr. Stabilized Finite Element Methods for Incompressible Flows with Emphasis on
Moving Boundaries and Interfaces. PhD thesis, University of Minnesota, Department
of Aerospace Engineering and Mechanics, 1992.
[23] M. Behr and D. Arora. Shear-slip mesh update method: Implementation and applications.
Computer Methods in Biomechanics and Biomedical Engineering, 6(2):113123, 2003.
[24] M. Behr, D. Arora, O. Coronado, and M. Pasquali. GLS-type nite element methods
for viscoelastic uid ow simulation. In Proceedings of the Third MIT Conference on
Computational Fluid and Solid Mechanics, pages 586589, Camebridge, Massachussetts,
2005.
[25] M. Behr, D. Arora, Y. Nose, and T. Motomura. Performance analysis of ventricular
assist devices using nite element ow simulation. International Journal for Numerical
Methods in Fluids, 46:12011210, 2004.
CFD Analysis of Blood Pumps 29
[26] M. Behr and T.E. Tezduyar. Finite element solution strategies for large-scale ow simu-
lations. Computer Methods in Applied Mechanics and Engineering, 112:324, 1994.
[27] A. N. Beris and B. J. Edwards. Thermodynamics of Flowing Systems with Internal Mi-
crostructure. Oxford University Press, Oxford, 1st edition, 1994.
[28] C.D. Bertram, Y. Qian, and J.A. Reizes. Computational uid dynamics performance
prediction of the hydrodynamic bearings of the VentrAssist rotary blood pump. Articial
Organs, 25(5):348357, 2001.
[29] P.L. Blackshear and G.L. Blackshear. Mechanical hemolysis. In R. Skalak and S. Chien,
editors, Handbook of Bioengineering, pages 15.115.19. McGraw-Hill, New York, 1987.
[30] C. Bludszuweit. Model for a general mechanical blood damage prediction. Articial
Organs, 19(7):583589, 1995.
[31] C. Bludszuweit. Three-dimensional numerical prediction of stress loading of blood particles
in a centrifugal pump. Articial Organs, 19(7):590596, 1995.
[32] C. Bludszuweit. Evaluation and optimization of articial organs by computational uid
dynamics. In Proceedings of 1997 ASME Fluids Engineering Division Summer Meeting,
1997.
[33] B. Bl umich. Essential NMR. Springer, Berlin, 2005.
[34] K. Boryczko, W. Dzwinel, and D.A. Yuen. Dynamical clustering of red blood cells in
capillary vessels. Journal of Molecular Modeling, 9:1633, 2003.
[35] A.N. Brooks and T.J.R. Hughes. Streamline upwind/Petrov-Galerkin formulations for
convection dominated ows with particular emphasis on the incompressible Navier-
Stokes equations. CMNA, 32:199259, 1982.
[36] G.W. Burgreen, J.F. Antaki, Z.J. Wu, and A.J. Holmes. Computational uid dynamics
as a development tool for rotary blood pumps. Articial Organs, 25(5):336340, 2001.
[37] W.K. Chan, Y.W. Wong, Y. Ding, L.P. Chua, and S.C.M. Yu. Numerical investigation
of the eect of blade geometry on blood trauma in a centrifugal blood pump. Articial
Organs, 26(9):785793, 2002.
[38] W.K. Chan, Y.W. Wong, W. Ong, S.-Y. Koh, and V. Chong. Numerical investigation
of the eects of the clearance gap between the inducer and impeller of an axial blood
pump. Articial Organs, 29(3):250258, 2005.
[39] S. Chien. Shear dependence of eective cell volume as determinant of blood viscosity.
Science, 168:977979, 1970.
[40] S. Chien, S. Usami, R.J. Dellenback, and M.I. Gregersen. Blood viscosity: Inuence of
erythrocyte aggregation. Science, 157:827829, 1967.
[41] S. Chien, S. Usami, R.J. Dellenback, and M.I. Gregersen. Blood viscosity: Inuence of
erythrocyte deformation. Science, 157:829831, 1967.
[42] O.M. Coronado, D. Arora, M. Behr, and M. Pasquali. Four-eld Galerkin/Least-squares
formulation for viscoelastic uids. Journal of Non-Newtonian Fluid Mechanics, 140:132
144, 2006.
[43] C. Couillette and C. Pozrikidis. Motion of an array of drops through a cylindrical tube.
Journal of Fluid Mechanics, 358:128, 1998.
[44] V. Cristini and G.S. Kassab. Computer modeling of red blood cell rheology in the micro-
circulation: a brief overview. Annals of Biomedical Engineering, 33:17241727, 2005.
[45] M. J. Crochet, A. R. Davies, and K. Walters. Numerical simulation of non-Newtonian
ow. Elsevier, New York, 1984.
[46] A.R. Curtas, H.G. Wood, P.E. Allaire, J.C. McDaniel, S.W. Day, and D.B. Olsen. Compu-
tational uid dynamics modeling of impeller designs for the HeartQuest left ventricular
assist device. ASAIO, 48:552561, 2002.
[47] J.J. Curtis and C. Wagner-Mann. Cardiac Assist Devices. Futura Publishing Co Inc.,
Armonk, New York, 2000.
[48] E.W. Davie. A brief historical review of the waterfall/cascade of blood coagulation. Journal
of Biological Chemistry, 278:5081950832, 2005.
30 M. Behbahani et al.
[49] S.W. Day and J.C. McDaniel. PIV measurements of ow in a centrifugal blood pump:
Time varying ow. ASME, 127:254263, 2005.
[50] D. De Wachter and P. Verdonck. Numerical calculation of hemolysis levels in peripheral
hemodialysis cannulas. Articial Organs, 26(7):576582, 2002.
[51] M.E. DeBakey. The odyssey of the articial heart. Articial Organs, 24(6):405411, 2000.
[52] W. Ding and S. Nakamura. Three-dimensional single passage simulation for the IVAS
centrifugal heart pump. In Proceedings of ASME Fluids Engineering Division Summer
Meeting, 1998.
[53] P.L. Easthope and D.E. Brooks. A comparison of rheological and constitutive functions
for whole human blood. Biorheology, 17:235247, 1980.
[54] D.M. Eckmann. Hematocrit, volume expander, temperature, and shear rate eects on
blood viscosity. Anesth Analg, 91:539545, 2000.
[55] C.D. Eggleton and A.S. Popel. Large deformation of red blood cell ghosts in a simple
shear ow. Physics of Fluids, 10(8):18341845, 1998.
[56] E.A. Evans and P.L. LaCelle. Intrinsic material properties of the erythrocyte membrane
indicated by mechanical analysis of deformation. Blood, 45:2943, 1975.
[57] L.P. Franca and S.L. Frey. Stabilized nite element methods: II. The incompressible
Navier-Stokes equations. CMAME, 99:209233, 1992.
[58] L.P. Franca, S.L. Frey, and T.J.R. Hughes. Stabilized nite element methods: I. Applica-
tion to the advective-diusive model. CMAME, 95:253276, 1992.
[59] Y.C. Fung. Biomechanics: Mechanical properties of living tissue. Springer-Verlag, New
York, 1981.
[60] F.J. Gauthier, H.L. Goldsmith, and S.G. Mason. Flow of suspensions through tubes. X.
Liquid drops as models of erythrocytes. Biorheology, 9:205224, 1972.
[61] M.P. Gawaz. Das Blutplattchen. Medinger Sohn & Co, Frankfurt, 1856.
[62] M. Giersiepen, L.J. Wurzinger, R. Opitz, and H. Reul. Estimation of shear stress-related
blood damage in heart valve prosthesesin vitro comparison of 25 aortic valves. Inter-
national Journal of Articial Organs, 13(5):300306, 1990.
[63] F.J.H. Gijsen, F.N. van de Vosse, and J.D. Janssen. The inuence of the non-Newtonian
properties of blood on the ow in large arteries: Steady ow in a carotid bifurcation
model. Journal of Biomechanics, 32:601608, 1999.
[64] L. Goubergrits and K. Aeld. Numerical estimation of blood damage in articial organs.
Articial Organs, 28(5):499507, 2004.
[65] M. Grigioni, C. Daniele, U. Morbiducci, G. DAvenio, G. Di Benedetto, and V. Barbaro.
The power-law mathematical model for blood damage prediction: Analytical develop-
ments and physical inconsistencies. Articial Organs, 28(5):467475, 2004.
[66] M. Grmela and P. J. Carreau. Conformation tensor rheological models. J. Non-Newtonian
Fluid Mech., 23:271294, 1987.
[67] L. Gu and W.A. Smith. Evaluation of computational models for hemolysis estimation.
ASAIO, 51:202207, 2005.
[68] R. Guenette, Z. Abdelmalek, A. Fortin, P. Carreau, and M. Grmela. Simulation of vis-
coelastic ows using a conformation tensor model. J. Non-Newtonian Fluid Mech.,
45:187208, 1992.
[69] S. Han, O. Marseille, C. Gehlen, and B. Bl umich. Rheology of blood by NMR. Journal
of Magnetic Resonance, 152:8794, 2001.
[70] J.D. Hellums and C.H. Brown, III. Blood cell damage by mechanical forces. In N.H.C
Hwang and N.A. Normann, editors, Cardiovascular Flow Dynamics and Measurements,
pages 799823. University Park Press, Baltimore, Maryland, 1977.
[71] S. Henon, G. Lenormand, A. Richert, and F. Gallet. A new determination of the shear
modulus of the human erythrocyte membrane using optical tweezers. Biophysical Jour-
nal, 76(February):11451151, 1999.
[72] R. Hetzer, J. M uller, Y. Weng, G. Wallukat, S. Spiegelsberger, and M. Loebe. Cardiac
CFD Analysis of Blood Pumps 31
recovery in dilated cardiomyopathy by unloading with a left ventricular assist device.
The Annals of Thorarcic Surgery, 68:742749, 1999.
[73] G. Heuser and R. Opitz. A Couette viscometer for short time shearing of blood. Biorhe-
ology, 17:1724, 1980.
[74] K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy. Survival after the
onset of congestive heart failure in Framingham heart study subjects. Circulation,
88:107115, 1993.
[75] J.I. Homann and R. Christianson. Congenital heart disease in a cohort of 19,502 births
with long-term follow-up. The American Journal of Cardiology, 42(4):641647, 1978.
[76] T.J.R. Hughes and A.N. Brooks. A multi-dimensional upwind scheme with no crosswind
diusion. In T.J.R. Hughes, editor, Finite Element Methods for Convection Dominated
Flows, AMD-Vol.34, pages 1935. ASME, New York, 1979.
[77] T.J.R. Hughes, L.P. Franca, and G.M. Hulbert. A new nite element formulation for
computational uid dynamics: VIII. the Galerkin/least-squares method for advective-
diusive equations. CMAME, 73:173189, 1989.
[78] M.A. Hulsen, R. Fattal, and R. Kupferman. Flow of viscoelastic uids past a cylinder at
high Weissenberg number: Stabilized simulations using matrix logarithms. Journal of
Non-Newtonian Fluid Mechanics, 127:2739, 2005.
[79] W. Johnson. Engineering Plasticity. VNR, London, 1973.
[80] M.V. Kameneva, G.W. Burgreen, K. Kono, B. Repko, J.F. Antaki, and M. Umezu. Ef-
fects of turbulent stresses upon mechanical hemolysis: Experimental and computational
analysis. ASAIO Journal, 50(5):418423, 2004.
[81] R. Keunings. Advances in the computer modeling of the ow of polymetric liquids. Com-
putational Fluid Dynamics Journal, 9:448458, 2001.
[82] S. Klaus, R. Paul, K. Mottaghy, H. Reul, and B. Glasmacher. Investigation of ow and
material induced hemolysis with a Couette type high shear system. Materialwissenschaft
und Werkzeugtechnik, 32:922925, 2001.
[83] B. Knierbein, H. Reul, R. Eilers, M. Lange, R. Kaufmann, and G. Rau. Compact mock
loops of the systemic and pulmonary circulation for blood testing. International Journal
of Articial Organs, 15(1):4048, 1992.
[84] S.S. Lee, K.H. Ahn, S.J. Lee, K. Sun, P.T. Goedhart, and M.R. Hardeman. Shear induced
damage of red blood cells monitored by the decrease of their deformability. Korea-
Australia Rheology Journal, 16(3):141146, 2004.
[85] A. Leuprecht and K. Perktold. Computer simulation of non-Newtonian eects on blood
ow in large arteries. Computer Methods in Biomechanics and Biomedical Engineering,
4:149163, 2001.
[86] L.B. Leverett, J.D. Hellums, C.P. Alfrey, and E.C. Lynch. Red blood cell damage by shear
stress. Biophysical Journal, 12:257273, 1972.
[87] P.L. Maettone and M. Minale. Equation of change for ellipsoidal drops in viscous ow.
Journal of Non-Newtonian Fluid Mechanics, 78:227241, 1998.
[88] T. Masuzawa, T. Tsukiya, S. Endo, E. Tatsumi, Y. Taenaka, H. Takano, T. Yamane,
M. Nishida, B. Asztalos, Y. Miyazoe, K. Ito, T. Sawairi, and Y. Konishi. Development
of design methods for a centrifugal blood pump with a uid dynamic approach: Results
in hemolysis tests. Articial Organs, 23(8):757761, 1999.
[89] K. Minami, S. Schulte-Eistrup, A. El-Banayosy, and R. Koerfer. Impact of regulatory
aairs on the development of articial organs, particularly ventricular assist devices.
Articial Organs, 25(5):860864, 2004.
[90] A. Mitoh, T. Yano, K. Sekine, Y. Mitamura, E. Okamoto, D. Kim, R. Yozu, and S. Kawada.
Computational uid dynamics analysis of an intra-cardiac axial ow pump. Articial
Organs, 27(1):3440, 2003.
[91] Y. Miyazoe, T. Sawairi, K. Ito, Y. Konishi, T. Yamane, M. Nishida, B. Asztalos, T. Ma-
suzawa, T. Tsukiya, S. Endo, and Y. Taenaka. Computational uid dynamics analysis
32 M. Behbahani et al.
to establish the design process of a centrifugal blood pump: Second report. Articial
Organs, 23(8):762768, 1999.
[92] T. Murakami, L.R. Golding, G. Jacobs, S. Takatani, R. Sukalac, H. Harasaki, and Y. Nose.
Nonpulsatile biventricular bypass using centrifugal blood pumps. Jap Soc Artif Organs,
8:636639, 1979.
[93] S. Nakamura. Options and selection of numerical algorithms for unsteady incompressible
Navier-Stokes equations. FEDSM97-3666, ASME Fluids Engineering Division Summer
Meeting, 1997.
[94] S. Nakamura and K. Yano. Computational simulation of ows in an entire centrifugal
blood pump. Articial Organs, 23(6):572575, 1999.
[95] B.T. Ng, W.K. Chan, and H.D. Li. Experimental and computational studies of the relative
ow eld in a centrifugal pump. Critical Reviews in Biomedical Engineering, 28(1):119
125, 2000.
[96] K. Nonaka, J. Linneweber, S. Ichikawa, M. Yoshikawa, S. Kawahito, M. Mikami, T. Mo-
tomura, H. Ishitoya, I. Nishimura, D. Oestmann, J. Glueck, H. Schima, E. Wolner,
T. Shinohara, and Y. Nose. Development of the Baylor Gyro permanently implantable
centrifugal blood pump as a biventricular assist device. Articial Organs, 25(9):675682,
2001.
[97] Y. Nose. Design and development strategy for the rotary blood pump. Articial Organs,
22(6):438446, 1998.
[98] Y. Nose. Is it a mistake to develop a totally implantable blood pump for destination
therapy? Articial Organs, 29(2):9394, 2005.
[99] Y. Nose, M. Yoshikawa, S. Murabayashi, and T. Takano. Development of rotary blood
pump technology: Past, present, and future. Articial Organs, 24(6):412420, 2000.
[100] E. Okamoto, T. Hashimoto, and T. Inoue. Blood compatible design of a pulsatile blood
pump using computational uid dynamics and computer-aided design and manufactur-
ing technology. Articial Organs, 27(1):6167, 2003.
[101] D.B. Olsen. Rotary blood pumps: A new horizon. Articial Organs, 23(8):695696, 1999.
[102] D.B. Olsen. The history of continuous-ow blood pumps. Articial Organs, 24(6):401404,
2000.
[103] R.G. Owens. A new microstructure-based constitutive model for human blood. Journal
of Non-Newtonian Fluid Mechanics, 140:5770, 2006.
[104] R.G. Owens and T.N. Phillips. Computational rheology. Imperial College Press, London,
2002.
[105] D. Papantonis. Numerical prediction of the shear stresses and the mean exposure time
for radial ow impellers. In Proceedings of the International Workshop on Rotary Blood
Pumps, pages 6369, Vienna, Austria, 1991.
[106] D. Papantonis and D. Croba. Numerical calculation of the performances and shear stresses
developed on centrifugal blood pumps. In Proceedings of the International Workshop
on Rotary Blood Pumps, pages 5359, Vienna, Austria, 1988.
[107] M. Pasquali and L. E. Scriven. Free surface ows of polymer solutions with models based
on the conformation tensor. J. Non-Newtonian Fluid Mech., 108:363409, 2002.
[108] M. Pasquali and L. E. Scriven. Theoretical modeling of microstructured liquids: a simple
thermodynamic approach. J. Non-Newtonian Fluid Mech., 120:101135, 2004.
[109] K. Perktold, G. Karner, A. Leuprecht, and M. Hofer. Inuence of non-Newtonian ow
behavior on local hemodynamics. Z. Angew. Math. Mech., 79:187190, 1999.
[110] M. Pinotti and E.S. Rosa. CFD simulation on the performance of parallel corotating disks
as a heart assist device. In Proceedings of the 6th Mediterranean Conference on Medical
and Biological Engineering, pages 429432, Capri, Italy, 1991.
[111] M. Pinotti and E.S. Rosa. Computational prediction of hemolysis in a centrifugal ventric-
ular assist device. Articial Organs, 19(3):267273, 1995.
[112] C. Pozrikidis. Modeling and simulation of capsules and biological cells. Chapman Hall,
Boca Raton, 2003.
CFD Analysis of Blood Pumps 33
[113] C. Pozrikidis. Numerical simulation of the ow-induced deformation of red blood cells.
Annals of Biomedical Engineering, 31:11941205, 2003.
[114] C. Pozrikidis. Numerical simulation of cell motion in tube ow. Annals of Biomedical
Engineering, 33:165178, 2004.
[115] Y. Qian and C.D. Bertram. Computational uid dynamics analysis of hydrodynamic
bearings of the VentrAssist rotary blood pump. Articial Organs, 24(6):488491, 2000.
[116] E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, W. Dembitsky,
J.W. Long, D.D. Ascheim, A.R. Tierney, R.G. Levitan, J.T. Watson, P. Meier, N.S.
Ronan, P.A. Shapiro, R.M. Lazar, L.W. Miller, L. Gupta, O.H. Frazier, P. Desvigne-
Nickens, M.C. Oz, and V.L. Poirier for the Randomized Evaluation of Mechanical As-
sistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group.
Long-term use of a left ventricular assistance for end-stage heart failure. The New
England Journal of Medicine, 345:143543, 2001.
[117] J.M. Rossi Neto. A dimensao do problema da insuciencia cardaca do Brazil e do mundo.
Revista da Sociedade de Cardiologia do Estado de Sao Paulo, 14(1):110, 2004.
[118] Y. Saad and M. Schultz. GMRES: A generalized minimal residual algorithm for solving
nonsymmetric linear systems. SIAM Journal of Scientic and Statistical Computing,
7:856869, 1986.
[119] E.J. Schaefer. Lipoproteins, nutrition, and heart disease. American Journal of Clinical
Nutrition, 75:191212, 2002.
[120] H. Schmid-Schonbein and R. Wells. Fluid drop-like transition of erythrocytes under shear.
Science, 165(3890):288291, 1969.
[121] M. Scott. The modeling of blood rheology in small vessels. PhD thesis, University of
Waterloo, Department of Applied Mathematics, 2005.
[122] T.W. Secomb, R. Hsu, and A.R. Pries. A model for red blood cell motion in glycocalyx-
lined capillaries. Modeling of Physiology, 274:10161022, 1998.
[123] P. Snabre and P. Mills. Rheology of weakly occulated suspensions of viscoelastic particles.
Journal de Physique III France, 6:18351855, 1996.
[124] X. Song, A. Throckmorton, H.G. Wood, J. Antaki, and D.B. Olsen. Quantitative evalu-
ation of blood damage in a centrifugal VAD by computational uid dynamics. ASME,
126:410418, 2004.
[125] X. Song, A.L. Throckmorton, A. Untaroiu, S. Patel, P.E. Allaire, H.G. Wood, and D.B.
Olsen. Axial ow blood pumps. ASAIO, 49(4):355364, 2003.
[126] X. Song, H.G. Wood, S.W. Day, and D.B. Olsen. Studies of turbulence models in a
computational uid dynamics model of a blood pump. Articial Organs, 27(10):935
937, 2003.
[127] X. Song, H.G. Wood, and D.B. Olsen. Computational uid dynamics (CFD) study of the
4th generation prototype of a continuous ow ventricular assist device (VAD). Journal
of Biomedical Engineering, 126:180187, 2004.
[128] A. Stepano. Centrifugal and axial ow pumps. New York: Krieger, 1957.
[129] J. Sun, M.D. Smith, R.C. Armstrong, and R.A. Brown. Finite element method for vis-
coelastic ows based on the discrete adaptive viscoelastic stress splitting and the discon-
tinuous Galerkin method: DAVSS-G/DG. Journal of Non-Newtonian Fluid Mechanics,
86:281307, 1999.
[130] S. Takatani. Can rotary blood pumps replace pulsatile devices? Articial Organs,
25(9):671674, 2001.
[131] S. Takatani, K. Ozawa, L. Golding, G. Jacobs, T. Murakami, F. Valdes, H. Harasaki,
R. Kiraly, and Y. Nose. Comparative evaluation of nonpulsatile and pulsatile cardiac
prostheses. Trans Am Soc Artif Intern Organs, 26:438443, 1980.
[132] K. Takiura, T. Masuzawa, S. Endo, Y. Wakisaka, E. Tatsumi, Y. Taenaka, H. Takano,
T. Yamane, M. Nishida, B. Asztalos, Y. Konishi, Y. Miyazoe, and K. Ito. Development
of design methods of a centrifugal blood pump with in vitro tests, ow visualization, and
34 M. Behbahani et al.
computational uid dynamics: Results in hemolysis tests. Articial Organs, 22(5):393
398, 1998.
[133] T.E. Tezduyar, S. Mittal, S.E. Ray, and R. Shih. Incompressible ow computations
with stabilized bilinear and linear equal-order-interpolation velocity-pressure elements.
CMAME, 95:221242, 1992.
[134] A. Throckmorton, A. Untaroiu, P.E. Allaire, H.G. Wood, G.P. Matherne, D.S. Lim, B.B.
Peeler, and D.B. Olsen. Computational analysis of an axial ow pediatric ventricular
assist device. Articial Organs, 28(10):881891, 2004.
[135] A.L. Throckmorton, H.G. Wood, S.W. Day, X. Song, P.C. Click, P.E. Allaire, and D.B.
Olsen. Design of a continuous ow centrifugal pediatric ventricular assist device. The
International Journal of Articial Organs, 26(11):10151031, 2003.
[136] G.B. Thurston. Rheological parameters for the viscosity, viscoelasticity and thixotropy of
blood. Biorheology, 16:149162, 1979.
[137] A.

Undar. Myths and truths of pulsatile and nonpulsatile perfusion during acute and
chronic cardiac support. Articial Organs, 28(5):439443, 2004.
[138] A. Untaroiu, H.G. Wood, P.E. Allaire, A.L. Throckmorton, S. Day, S.M. Patel, P. Ellman,
C. Tribble, and D.B. Olsen. Computational design and experimental testing of a novel
axial ow LVAD. ASAIO, 51:702710, 2005.
[139] R. Virchow. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Medinger Sohn
& Co, Frankfurt, 1856.
[140] N. Watanabe, O. Karsak, F. Neudel, T. Kink, J. Apel, T. Fujimoto, H. Reul, and
S. Takatani. Simulation of the BP-80 blood pump. Articial Organs, 25(9):733739,
2001.
[141] N. Watanabe, T. Masuda, T. Iida, H. Kataoka, T. Fujimoto, and S. Takatani. Quantica-
tion of the secondary ow in a radial coupled centrifugal blood pump based on particle
tracking velocimetry. Articial Organs, 29(1):2635, 2005.
[142] R.E. Waugh and R.M. Hochmuth. Mechanics and deformability of hematocytes. In J.D.
Bronzino, editor, Handbook of Bioengineering, pages 474486. CRC Press, 1995.
[143] H.G. Wood, A.L. Throckmorton, A. Untaroiu, and X.Song. The medical physics of ven-
tricular assist devices. Reports on Progress in Physics, 68:545576, 2005.
[144] D.M. Wootton and D.N. Ku. Fluid mechanics of vascular systems, diseases, and throm-
bosis. Annual Review of Biomedical Engineering, 1999.01:299329, 1999.
[145] J. Wu, J.F. Antaki, W.R. Wagner, T.A. Snyder, B.E. Paden, and H.S. Borovetz. Elim-
ination of adverse leakage ow in a miniature pediatric centrifugal blood pump by
computational uid dynamics-based design optimization. ASAIO, 51:636643, 2005.
[146] Y. Wu, P. Allaire, and G. Tao. An adaptive speed/ow controller for a continuous ow left
ventricular asssist device. In Proceedings of the American Control Conference, Denver,
Colorado, 2003.
[147] L.J. Wurzinger, R. Opitz, and H. Eckstein. Mechanical bloodtrauma. An overview.
Angeiologie, 38(3):8197, 1986.
[148] T. Yamaguchi, T. Ishikawa, K. Tsubota, Y. Imai, M. Nakamura, and T. Fukui. Computa-
tional blood ow analysis new trends and methods. Journal of Biomechanical Science
and Engineering, 1:2950, 2006.
[149] T. Yamane, B. Asztalos, M. Nishida, T. Masuzawa, K. Takiura, Y. Taenaka, Y. Konishi,
Y. Miyazoe, and K. Ito. Flow visualization as a complementary tool to hemolysis testing
in the development of centrifugal blood pumps. Articial Organs, 22(5):375380, 1998.
[150] T. Yamane, Y. Miyamoto, K. Tajima, and K.Yamazaki. A comparative study between ow
visualization and computational uid dynamic analysis for the Sun Medical centrifugal
blood pump. Articial Organs, 28(5):458466, 2004.
[151] K. Yano and S. Nakamura. Flow simulation of the IVAS heart pump using a parallel
computer, T3D. In Proceedings of ASME Fluids Engineering Division Summer Meeting,
Vancouver, Canada, 1997.
[152] T. Yano, K. Sekine, A. Mitoh, Y. Mitamura, E. Okamoto, D.-W. Kim, I. Nishimura,
CFD Analysis of Blood Pumps 35
S. Murabayashi, and R. Yozu. An estimation method of hemolysis within an axial ow
blood pump by computational uid dynamics analysis. Articial Organs, 27(10):920
925, 2003.
[153] T. Yasuda, K. Shimokasa, A. Funakubo, T. Higami, T. Kawamura, and Y. Fukui. An inves-
tigation of blood ow behavior and hemolysis in articial organs. ASAIO, 46(5):527531,
2000.
[154] K.K. Yeleswarapu. Evaluation of Continuum Models for Characterizing the Constitutive
Behavior of Blood. PhD thesis, University of Pittsburgh, Department of Mechanical
Engineering, 1996.
[155] K.K. Yeleswarapu, J.F. Antaki, M.V. Kameneva, and K.R. Rajagopal. A mathematical
model for shear-induced hemolysis. Articial Organs, 19(7):576582, 1995.
[156] K.K. Yeleswarapu, M.V. Kameneva, K.R. Rajagopal, and J.F. Antaki. The ow of blood in
tubes: Theory and experiments. Mechanics Research Communications, 25(3):257262,
1998.
[157] M. Yoshikawa, K. Nonaka, J. Linneweber, S. Kawahito, G. Ohtsuka, K. Nakata, T. Takano,
S. Schulte-Eistrup, J. Glueck, H. Schima, E. Wolner, and Y. Nose. Development of the
NEDO implantable ventricular assist device with Gyro centrifugal pump. Articial
Organs, 24(6):459467, 2000.
[158] R. Yozu, L.R. Golding, G. Jacobs, H. Harasaki, and Y. Nose. Experimental results and fu-
ture prospects for a nonpulsatile cardiac prosthesis. World Journal of Surgery, 9(1):116
127, 1985.
[159] S.C.M. Yu, B.T.H. Ng, W.K. Chan, and L.P. Chau. The ow patterns within the impeller
passage of a centrifugal blood pump model. Medical Engineering and Physics, 22:381
393, 2000.
[160] K. Yuri, H. Iwahashi, T. Motomura, A. Hata, T. Asai, Y. Nose, D. Arora, M. Behr, and
M. Pasquali. Dierent levels of hemolysis occurred by a centrifugal blood pump in
various clinical conditions. ASAIO Journal, 50(2):121, 2004. ASAIO 50th Anniversary
Conference Abstracts.
[161] J. Zhang, B. Gellman, A. Koert, K.A. Dasse, R.J. Gilbert, B.P. Grith, and Z.J. Wu.
Computational and experimental evaluation of the uid dynamics and hemocompati-
bility of the CentriMag blood pump. Articial Organs, 30(3):168177, 2006.
[162] J.B. Zhang and Z.B. Kuang. Study on blood constitutive parameters in dierent blood
constitutive equations. Journal of Biomechanics, 33:355360, 2000.

Das könnte Ihnen auch gefallen